At Molinette Hospital in Turin, the university urology department led by Prof. Paolo Gontero has marked a turning point in prostate cancer surgery: EchoLaser TPLA (Transperineal Laser Ablation). This focal therapy, performed by Marco Oderda and Alessandro Marquis,...
On July 25th, 2025, at the Verona University Hospital (AOUI Verona), Professor Alessandro Antonelli and his team successfully performed three treatments for benign prostatic hyperplasia (BPH) and one focal therapy for prostate cancer using the EchoLaser system with...
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership. Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite. It is a novel technique which is...
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy.
